+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood & Plasma Components Market by Product Type (Plasma Proteins, Platelets, Red Blood Cells), Application (Diagnostic, Research, Therapeutic), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Blood & Plasma Components Market by Product Type (Plasma Proteins, Platelets, Red Blood Cells), Application (Diagnostic, Research, Therapeutic), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Blood & Plasma Components Market by Product Type (Plasma Proteins, Platelets, Red Blood Cells), Application (Diagnostic, Research, Therapeutic), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010964
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood and plasma components market is evolving rapidly, underpinning essential therapies and diagnostics in today’s healthcare landscape. Strategic innovation, resilient supply networks, and evolving clinical demands are shaping the industry’s future, offering new opportunities for global stakeholders committed to quality patient care.

Market Snapshot: Blood & Plasma Components Market Overview

The Blood & Plasma Components Market grew from USD 45.86 billion in 2024 to USD 48.62 billion in 2025. It is expected to increase at a CAGR of 5.75%, reaching USD 64.15 billion by 2030. This stable upward trajectory reflects strong underlying demand, the ongoing need for advanced therapeutics, and expanding clinical applications worldwide. Senior decision-makers are recognizing the sector’s strategic significance amidst regulatory shifts, modernized supply chains, and expanding end-user groups.

Scope & Segmentation

This report addresses comprehensive segmentation analysis to enable effective planning, resource allocation, and risk mitigation:

  • Product Types: Plasma proteins, platelets, red blood cells, white blood cells
  • Plasma Proteins: Albumin, coagulation factors, immunoglobulins, including Factor IX, Factor VIII, prothrombin complex concentrates, intravenous immunoglobulin, subcutaneous immunoglobulin
  • Applications: Diagnostic, research, therapeutic
  • End Users: Diagnostic laboratories, hospitals (ambulatory surgical centers, government and private hospitals), research institutions
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • Coverage Regions: Americas (including detailed coverage in the US, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including the UK, Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, and other key countries), Asia-Pacific (with China, India, Japan, Australia, South Korea, and others)
  • Technologies: Automated fractionation, high-throughput purification, digital traceability, data analytics
  • Key Companies: CSL Limited, Grifols S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, Biotest AG, KEDRION S.p.A., Shanghai RAAS, Bio Products Laboratory Limited, LFB S.A., Sanquin Blood Supply Foundation

Key Takeaways for Senior Decision-Makers

  • Product innovation is expanding clinical use cases, enabling more precise and patient-centric therapeutic approaches.
  • Quality and consistency are improving through advanced purification and digital tracking, supporting enhanced safety and regulatory compliance.
  • Strategic partnerships between biopharma, diagnostic labs, and manufacturers are accelerating product development timelines and market entry.
  • Operational resilience is increasingly critical as companies respond to evolving regulatory oversight, complex supply chains, and fluctuating sourcing conditions.
  • Regional heterogeneity requires adaptive strategies to navigate diverse infrastructure capabilities, healthcare needs, and policy environments across major geographic markets.

Tariff Impact on Blood & Plasma Components

Recent United States tariff proposals are introducing higher production and procurement costs, prompting industry players to prioritize domestic manufacturing and reinforce local supply chains. These adjustments are driving new investments in infrastructure and workforce competency. Distributors and healthcare providers are recalibrating procurement strategies, which is refocusing attention on inventory management and long-term supplier agreements to maintain consistent access to vital components.

Methodology & Data Sources

This report combines extensive primary research—including in-depth interviews with industry stakeholders and anonymized surveys—with secondary validation from regulatory filings, peer-reviewed publications, and company disclosures. Data triangulation and cross-functional expert review uphold the validity and relevance of all findings.

Why This Report Matters

  • Informs high-impact, evidence-based decisions for investment, partnership, and product development within the blood and plasma sector.
  • Enables risk mitigation by benchmarking regulatory and supply chain shifts that could affect operational continuity or cost projections.
  • Offers actionable insights on adapting to clinical, operational, and regional trends for sustained competitive advantage.

Conclusion

The Blood & Plasma Components Market continues to transform through technology, strategic collaboration, and adaptive risk management. This analysis empowers industry leaders to anticipate change, optimize operations, and elevate patient outcomes by leveraging robust data and market insights.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing demand for recombinant albumin alternatives driven by supply constraints in human plasma
5.2. Development of hyperimmunoglobulin therapies targeting emerging infectious diseases to bolster passive immunity
5.3. Expansion of fractionation capacity in Asia Pacific to meet rising demand for immunoglobulin therapies
5.4. Adoption of pathogen reduction technologies in blood processing to enhance transfusion safety standards
5.5. Growing investment in continuous flow plasmapheresis devices to improve donor throughput and efficiency
5.6. Rising corporate consolidation among plasma fractionators reshaping competitive dynamics and pricing
5.7. Shift towards decentralized blood banking models using point-of-care testing to expand rural accessibility
5.8. Integration of artificial intelligence for predictive donor screening and supply chain optimization
5.9. Emergence of recombinant coagulation factors reducing dependency on plasma-derived concentrates
5.10. Implementation of novel viral inactivation methods to address safety concerns in plasma products
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood & Plasma Components Market, by Product Type
8.1. Introduction
8.2. Plasma Proteins
8.2.1. Albumin
8.2.2. Coagulation Factors
8.2.2.1. Factor IX
8.2.2.2. Factor VIII
8.2.2.3. Prothrombin Complex Concentrates
8.2.3. Immunoglobulins
8.2.3.1. Intravenous Immunoglobulin
8.2.3.2. Subcutaneous Immunoglobulin
8.3. Platelets
8.4. Red Blood Cells
8.5. White Blood Cells
9. Blood & Plasma Components Market, by Application
9.1. Introduction
9.2. Diagnostic
9.3. Research
9.4. Therapeutic
10. Blood & Plasma Components Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.3.1. Ambulatory Surgical Centers
10.3.2. Government Hospitals
10.3.3. Private Hospitals
10.4. Research Institutions
11. Blood & Plasma Components Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Blood & Plasma Components Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood & Plasma Components Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood & Plasma Components Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. CSL Limited
15.3.2. Grifols, S.A.
15.3.3. Takeda Pharmaceutical Company Limited
15.3.4. Octapharma AG
15.3.5. Biotest AG
15.3.6. KEDRION S.p.A.
15.3.7. Shanghai RAAS Blood Products Co., Ltd
15.3.8. Bio Products Laboratory Limited
15.3.9. LFB S.A.
15.3.10. Sanquin Blood Supply Foundation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD & PLASMA COMPONENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BLOOD & PLASMA COMPONENTS MARKET: RESEARCHAI
FIGURE 24. BLOOD & PLASMA COMPONENTS MARKET: RESEARCHSTATISTICS
FIGURE 25. BLOOD & PLASMA COMPONENTS MARKET: RESEARCHCONTACTS
FIGURE 26. BLOOD & PLASMA COMPONENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLOOD & PLASMA COMPONENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ALBUMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY FACTOR IX, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY FACTOR VIII, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLATELETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLATELETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 112. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 113. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 114. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 115. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 116. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 117. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 215. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 231. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 258. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 259. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 260. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 261. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 262. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 263. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 284. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 285. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Blood & Plasma Components market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Biotest AG
  • KEDRION S.p.A.
  • Shanghai RAAS Blood Products Co., Ltd
  • Bio Products Laboratory Limited
  • LFB S.A.
  • Sanquin Blood Supply Foundation

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 48.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 64.15 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

2025 Human Red Blood Cell Collection, Processing, and Distribution Services Global Market Size & Growth Report with Updated Recession Risk Forecasts by Country - Product Image

2025 Human Red Blood Cell Collection, Processing, and Distribution Services Global Market Size & Growth Report with Updated Recession Risk Forecasts by Country

  • Report
  • 45 Pages
  • Global
From
Blood Plasma Derivatives Market by Source (Plasma Derived, Recombinant), End User (Hemophilia Treatment Centers, Home Care, Hospitals), Distribution Channel, Product Type, Application - Global Forecast 2025-2030 - Product Image

Blood Plasma Derivatives Market by Source (Plasma Derived, Recombinant), End User (Hemophilia Treatment Centers, Home Care, Hospitals), Distribution Channel, Product Type, Application - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033 - Product Image

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033

  • Report
  • 149 Pages
  • Global
From
Blood Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Blood Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Plasma Fractionation Market by Product Type (Albumin, Coagulation Factor Concentrates, Immunoglobulins), Method of Fractionation (Centrifugation, Cryoprecipitation, Ethanol Precipitation), Application, End-User - Global Forecast 2025-2030 - Product Image

Plasma Fractionation Market by Product Type (Albumin, Coagulation Factor Concentrates, Immunoglobulins), Method of Fractionation (Centrifugation, Cryoprecipitation, Ethanol Precipitation), Application, End-User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.